Long-Term Effects of Autologous Bone Marrow Stem Cell Treatment in Acute Myocardial Infarction: Factors That May Influence Outcomes

• David M. Clifford,

  Current address: University of Melbourne, Melbourne, Australia

  Affiliations Stem Cell Research Laboratory, NHS-Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom

  ⨯
• Sheila A. Fisher,

  Affiliation Systematic Review Initiative, Clinical Research Group, NHSBT-Oxford, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Susan J. Brunskill,

  Affiliation Systematic Review Initiative, Clinical Research Group, NHSBT-Oxford, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Carolyn Doree,

  Affiliation Systematic Review Initiative, Clinical Research Group, NHSBT-Oxford, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Anthony Mathur,

  Affiliations Department of Clinical Pharmacology, William Harvey Research Institute, London, United Kingdom, Barts and the London NIHR Biomedical Research Unit, London, United Kingdom

  ⨯
• Mike J. Clarke,

  Affiliation All-Ireland Hub For Trials Methodology Research, Queen’s University, Belfast, United Kingdom

  ⨯
• Suzanne M. Watt,

  Affiliations Stem Cell Research Laboratory, NHS-Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom

  ⨯
• Enca Martin-Rendon

  * E-mail: enca.rendon@ndcsl.ox.ac.uk

  Affiliations Stem Cell Research Laboratory, NHS-Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom

  ⨯